Treatment-Resistant Depression
1987; Slack Incorporated (United States); Volume: 17; Issue: 4 Linguagem: Inglês
10.3928/0048-5713-19870401-13
ISSN1938-2456
AutoresK. Geoffrey White, George M. Simpson,
Tópico(s)Bipolar Disorder and Treatment
ResumoPsychopharmacology UpdateTreatment-Resistant Depression Kerrin White, MD, , and , MD George Simpson, MD, , MD Kerrin White, MD and George Simpson, MD Published Online:April 01, 1987https://doi.org/10.3928/0048-5713-19870401-13PDFView Full Text ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinkedInRedditEmail SectionsMore1. Price LH, Charney DS. Hemnger GR: Variability of response to lithium augmentation in refractory depression. Am J Psychiatry 1986; 143:1387-1392. Google Scholar2. Quitkin KM, Rabkin IG. Ross D. et al: Duration of antidepressant drug treatment. Arch UfM Psvchiatry 1984; 41:238-245. Google Scholar3. Simpson GM, Lee |H. Cuculic Z. et al: Two dosages of imipramine in hospitalized endogenous and neurotic depressives. Arch GfH Psychiatry 1976: 33:1093-1102. Google Scholar4. Simpson G. Pi E, White K; Plasma drug levels and clinical response to antidcpressants. J Clin Psychiatry 1983; 44:91-93. Google Scholar5. Schicle BC: The Parnate-spedie patient. Mimi Medi 96 5; 48:355-357. Google Scholar6. Himmelhoch JM, Detrc T. Kupfer Dl. et al: Treatment of previously intractable depressions with iranylcypromine and lithium. J Nerv Men't DAs 1972; 155:216-220. Google Scholar7. Georgotas A. Friedman E. McCarthy M, et al: Resistant geriatric depressions and therapeutic response to monoaminc oxidase inhibitors. Biol Psvchiatry 1983; 18:195-205. Google Scholar8. Price LH. Charncy DS, Hcningcr GR: Efficacy of lithium -tranykypromine treatment in rclractory depression. Am I Psvchiatry 1985; 142:619-023. Google Scholar9. Nolen WA. Van De Putte II, DiJ ken WA, et al: L-5HTP in depression resistant to re-uptake inhibitors: An open comparative study with tranvicyromine. Br J Psychiatry 1985: 147:16-22. Google Scholar10. White K, Simpson G: Combined MAOliricyclic antidepressant treatment: A revaluation. J Clin Psychopharmacol 1481; 1:264-282. Google Scholar11. White K. Simpson G: The combined use of MAOIs and tricyclics. iClin Psvchiatry 1984i 45:67-69. Google Scholar12. Davidson J, McLeod M. Law- Yone B. et al: A comparison of electroconvulsive therapy and combined phcnclzineamitriptyline in refractory depression. Arch Gen Psychiatry 1978; 35:639-642. Google Scholar13 Young IPR. Lader MH. Hughes WC: Controlled trial of trimipramine. monoamine oxidase inhibitors, and combined phenelzine-amitriptyline in refractory depression. Arch Gen Psychiatry 1979. 35:639-642. Google Scholar14. White K. Pistole JL. Boyd IL: Combined MAOI-TCA vs. single antidepressant treatment: A pilot study. Am J Psychiatry 1980: 137:1422-1425. Google Scholar15. Kazan: J. White K. O'Leary J. et al: The safety and efficacy of combined amitriptyline and iranylcypromine amidepressant treatment: A controlled trial. Arch Gen Psychiatry 1983; 40:657-661. Google Scholar16. De Montigny C. Grunberg F. Mayor A. et al: Lithium induces rapid relief of depression in tricyclic antidepressanl drug non-responders. Br J Psychiatry 1981 : 138:252-256. Google Scholar17. De Montigny C, Cournoyer G. Morisette R, el al: Lithium carbonate addition in tricyclic ant idepressant-resistant unipolar depression. Arch Gen Psychiatry 1983; 40:1327-1334. Google Scholar18. Heninger GR. Charney DS. Sternberg DE: Lithium carbonate augmentation of antidepressanl treatment. .Arch Gen Psychiatry 1983; 40:1335-1342. Google Scholar19. Nelson IC. M azure CM: Lithium augmentation in psychotic depression refractory to combined drug treatment. Am J Psychiatry 1986; 143:363-366. Google Scholar20. Price LH. Charncy DS. Hcninger GR: Variability of response to lithium augmentation in refractory depression. Am J Psychiatry 1986; 143M387-1392. Google Scholar21. Ramsey TA. Mendels I: Lithium ion as an antidepressant. in Enna SJ. Malick JB. Richelson E (eds): Antidepressants: Neurochemical, Bechavioral, and Clinical Perspectives. New York. Raven Press. 1981. Google Scholar22. Karle BV: Thyroid hormone and tricyclic antideprcssants in resistant depressions. Am J Psychiatry 1981; 138:252-256. Google Scholar23. Coppen A. Whybrow PC. Noguera R. et al: The comparative antidepressant value of L-tryptophan and imipramine with and without attempted potentiation by liothyronine. Arch Gen Psychiatry 1972; 26:234-241. Google Scholar24. Goodwin FK. Prange AJ. Post RM. et al: Potentiation of antidepressant effects by L-triiodothyronine in tricyclic non res ponders. Am J Psychiatry 1982: 139:34-38. Google Scholar25. Ogura C, Okuma T. Uchida Y. et al: Combined thyroid (triodothyronine)-tricyclic antidepressanl treatment in depressive states. Fulid Psychiaitr Neurol Jpn 1974: 28:179-186. Google Scholar26. Prange AJ Jr. Wilson IC. Breese GR. et al: Hormona! alteration of imipramine response: A review, in Sachar EJ (ed): Hormones, Behavi r. and Psychopathology. New York, Raven Press, 1976. Google Scholar27. Feighner IP. King LJ, Schtickit MA, et al: Hormonal potentiation of imipramine and ECT in primary epression. Am J Psychiatry- 1972: 128:"50-58. Google Scholar28. Targum SD. Green berg RD. Harmon RL. et al: The TRH test and thyroid hormone in retract o ry depression. Am i Psychiatry 1984; 141:463. Google Scholar29. D'Elia G, Hanson L. Raolma H: L-tryptophan and 5-hydroxytryptophan in the treatment of depression. A review. Acta Psychiatr Scand 1978; 57:239-252. Google Scholar30. Van Praag HM: Management of depression with scrotonin precursors, Biol Psychiatry 1981: 16:291-310. Google Scholar31. Wharton RN. Perel JM. Daytun PG. et al: A potential clinical use for methylphenidate with tricyclic antidepressants. Am J Psychiatry 1971; 127:55-61. Google Scholar32. Poldinger W: Combined administration of desipramine and reserpine or tetrahenzinc in depressive patients. Psychophartnacolugia 1963; 4:308-310. Google Scholar33. Haskovec L, Rybanek K: The action of reserpine in imipra mine-resistant depressive patients. Psvchupharmacologia 1967; 11:18-30. Google Scholar34. Hopkinson G. Kenny F: Treatment with reserpine of patients resistant to tricyclic antidcpressanls. Psychiair ? a; 1975; 8:109-114, Google Scholar35. Vogel W. Klaiber EL. Oro verm a n DM: Roles ol the gonadal steroid hormones in psychiatric depression in men and women. Prog Nettropsychopharmacol Biol Psychiatry 1978: 2:487-503. Google Scholar36. Cole. 10, Schatzberg AF. Sniffin C. et al: Trazodonc in treatment-resistant depression: An open study. J Clin Psvchophanncol 1981; l(Sup'pl):49-54. Google Scholar37. Post RM. Uhde TW. Roy-Hyrne PP, et al: Antidcpressant effects of carbamazepinc. Am J Psychiatry 1986: 143:29-34. Google Scholar38. Davidson JRT. McLeod MN. Kurland AA. et al: Antidepressant drug therapy in psychotic depression, Br J Psychiatry 1977: 131:493-496. Google Scholar39. Charney DS. Nelson JC: Delusional and nondelusional unipolar depression: Further evidence for distinct subtypes. Am J Psychiatry 1981: 138:328-333". Google Scholar40. Spiker DG. Weiss JC, Dealy RS, et al: The pharmacological treatment of delusional depression. Am J Psychiatry 1985: 142:430-436. Google Scholar41. Shaw DM. Hewland R: The management of resistant depression. Br J Psychiatry 1973: 123:489-492. Google Scholar42. Shaw DM: The practical management of affective disorders. Br J Psychiatry 1977: 130:432-451. Google Scholar43. Gemer RH : Systematic treatment approach to depression and treatment resistant depression. Psychiatric Annuls 1983; 13:37-49. Google Scholar44. Simpson G, Whiff K: Clinical uses of monoamine oxidase inhibitors. Hosp Community Psychiatry I 982 : 3 3: 615-616. Google Scholar Previous article Next article FiguresReferencesRelatedDetails Request Permissions InformationCopyright 2013, SLACK IncorporatedPDF download
Referência(s)